Navigation Links
Paleotempestology and 2011's Hurricane Irene
Date:11/27/2013

Boulder, Colorado, USA A new study published in the December issue of GSA Today examines the geological legacy of Hurricane Irene, not only in terms of its impact on current coastal conditions but also in what it can tell geoscientists about the past. Hurricane Irene made landfall in Onslow Bay, North Carolina, USA, on 27 August 2011, at which time it had been downgraded to a Category 1 hurricane after hitting the Bahamas at Category 3 strength.

In their GSA Today article, geoscientists Scott P. Hippensteel, Matthew D. Eastin, and William J. Garcia of the University of North Carolina at Charlotte call for a better understanding of the long-term record of storm frequency and impact, not only because of the increase in the strength of storms hitting coastal areas but also because of the high population density in vulnerable areas along the U.S. East Coast and Gulf Coast.

Those who study the paleo-storm record explain that gaining understanding of past events provides the context for future coastal vulnerability. Hippensteel and colleagues apply evidence of what they call the "lack of a definitive signature" from Hurricane Irene to a 1500-year paleostorm record at Onslow Bay. They write that fewer hurricanes could be found in the fossil and sedimentary records (through bioturbation or foraminiferal dissolution) than had actually made landfall there.

The authors infer that the lack of storm records in the marsh sediments from Onslow Bay means that only hurricane strikes of higher magnitude can provide proxies for understanding the paleostorm record, because only the most robust storm deposits are archived. The lack of definitive signs of Hurricane Irene in the area raises their concerns about the current understanding of hurricane deposition and preservation.


'/>"/>

Contact: Kea Giles
kgiles@geosociety.org
Geological Society of America
Source:Eurekalert  

Page: 1

Related biology news :

1. Studies of Desoto canyon and shelf in Gulf of Mexico uncover upwelling during Hurricane Isaac
2. USAs ancient hurricane belt and the US-Canada equator
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Paleotempestology and 2011's Hurricane Irene
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: